Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Pilgrim

Showing results (271-280 of 430) with videos related to

Pageof 43
Sort By:
Journal of the American Heart Association|September 27, 2015
Validation of the Valve Academic Research Consortium Bleeding Definition in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve ImplantationStefan Stortecky, Giulio G Stefanini, Thomas Pilgrim, et al.
Circulation. Cardiovascular Interventions|June 6, 2015
Clinical outcomes according to diabetic status in patients treated with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: prespecified subgroup analysis of the BIOSCIENCE trialAnna Franzone, Thomas Pilgrim, Dik Heg, et al.
Minerva Medica|June 12, 2020
HAS-BLED score and actual bleeding in elderly patients undergoing transcatheter aortic valve implantationFrancesca Ziviello, Thomas Pilgrim, Herbert Kroon, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 6, 2017
A comparison of an ultrathin-strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the BIOSTEMI trialJuan F Iglesias, Olivier Muller, Serge Zaugg, et al.
Lancet (London, England)|October 28, 2023
Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trialJuan F Iglesias, Marco Roffi, Sylvain Losdat, et al.
Journal of the American Heart Association|November 24, 2021
Effect of Timing of Staged Percutaneous Coronary Intervention on Clinical Outcomes in Patients With Acute Coronary SyndromesTatsuhiko Otsuka, Sarah Bär, Sylvain Losdat, et al.
JACC. Cardiovascular Interventions|September 22, 2022
Transvalvular Pressure Gradients and All-Cause Mortality Following TAVR: A Multicenter Echocardiographic and Invasive RegistryHouman Khalili, Philippe Pibarot, Rebecca T Hahn, et al.
JACC. Cardiovascular Interventions|May 7, 2021
Validation of the 2019 Expert Consensus Algorithm for the Management of Conduction Disturbances After TAVRDaniel Malebranche, Joanna Bartkowiak, Christoph Ryffel, et al.
Heart Rhythm|August 19, 2021
Permanent pacemaker implantation late after transcatheter aortic valve implantationElena Elchinova, Nikolas Nozica, Joanna Bartkowiak, et al.
BMC Cardiovascular Disorders|April 19, 2022
Diagnostic performance of quantitative coronary artery disease assessment using computed tomography in patients with aortic stenosis undergoing transcatheter aortic-valve implantationDaniel Malebranche, Maximilian K M Hoffner, Adrian T Huber, et al.
Pageof 43

Showing results (271-280 of 430) with videos related to

Sort By:
Pageof 43
Journal of the American Heart Association|September 27, 2015
Validation of the Valve Academic Research Consortium Bleeding Definition in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve ImplantationStefan Stortecky, Giulio G Stefanini, Thomas Pilgrim, et al.
Circulation. Cardiovascular Interventions|June 6, 2015
Clinical outcomes according to diabetic status in patients treated with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: prespecified subgroup analysis of the BIOSCIENCE trialAnna Franzone, Thomas Pilgrim, Dik Heg, et al.
Minerva Medica|June 12, 2020
HAS-BLED score and actual bleeding in elderly patients undergoing transcatheter aortic valve implantationFrancesca Ziviello, Thomas Pilgrim, Herbert Kroon, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 6, 2017
A comparison of an ultrathin-strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the BIOSTEMI trialJuan F Iglesias, Olivier Muller, Serge Zaugg, et al.
Lancet (London, England)|October 28, 2023
Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trialJuan F Iglesias, Marco Roffi, Sylvain Losdat, et al.
Journal of the American Heart Association|November 24, 2021
Effect of Timing of Staged Percutaneous Coronary Intervention on Clinical Outcomes in Patients With Acute Coronary SyndromesTatsuhiko Otsuka, Sarah Bär, Sylvain Losdat, et al.
JACC. Cardiovascular Interventions|September 22, 2022
Transvalvular Pressure Gradients and All-Cause Mortality Following TAVR: A Multicenter Echocardiographic and Invasive RegistryHouman Khalili, Philippe Pibarot, Rebecca T Hahn, et al.
JACC. Cardiovascular Interventions|May 7, 2021
Validation of the 2019 Expert Consensus Algorithm for the Management of Conduction Disturbances After TAVRDaniel Malebranche, Joanna Bartkowiak, Christoph Ryffel, et al.
Heart Rhythm|August 19, 2021
Permanent pacemaker implantation late after transcatheter aortic valve implantationElena Elchinova, Nikolas Nozica, Joanna Bartkowiak, et al.
BMC Cardiovascular Disorders|April 19, 2022
Diagnostic performance of quantitative coronary artery disease assessment using computed tomography in patients with aortic stenosis undergoing transcatheter aortic-valve implantationDaniel Malebranche, Maximilian K M Hoffner, Adrian T Huber, et al.
Pageof 43